MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    The role of stimulation parameters on cognitive performance in Essential Tremor with DBS ViM

    J. Kane, J. Neimat, S. Wylie, F. Phibbs, P. Hedera, V. Holiday, N. van Wouwe (Louisville, USA)

    Objective: We examined the role of DBS stimulation parameters on action control performance in ET. Background: DBS is an effective treatment for the motor symptoms…
  • 2022 International Congress

    Alterations of the gustatory circuit underly taste disturbances after lesional tremor therapy with MRgFUS

    V. Purrer, N. Upadhyay, V. Borger, C. Schmeel, H. Boecker, U. Wuellner (Bonn, Germany)

    Objective: Identification of structural brain alterations in patients with essential tremor (ET) reporting taste disturbances after magnetic resonance-guided focused ultrasound (MRgFUS) treatment. Background: Paraesthesias and…
  • 2022 International Congress

    Anti-IgLON5 mediated autoimmune encephalitis presenting with hemichorea

    A. Grossauer, A. Hussl, P. Mahlknecht, A. Heidbreder, K. Seppi, B. Heim (Innsbruck, Austria)

    Objective: In the present case report, we aim to describe a patient suffering from a seldom autoimmune encephalitis presenting with isolated progressive hemichorea. Background: Anti-IgLON5…
  • 2022 International Congress

    SAFINAMIDE: REAL LIFE STUDY. EFFICACY IN SWITCH FROM RASAGILINA AND LOW-DOSE TREATMENT.

    MI. Morales-Casado, N. López-Ariztegui, DD. García-Meléndez, A. Diezma-Martín (Toledo, Spain)

    Objective: Evaluate the efficacy of safinamide in fluctuations in Parkinson's disease in real life. Analysis by subgroups: Switch rasagiline to safinamide and treatment with low…
  • 2022 International Congress

    IMPACT OF COVID 19 ON PARKINSON’S DISEASE: A CROSS SECTIONAL STUDY

    G. Desai, T. Nanayakkara, G. Pun, A. Chatterjee, N. Butt (READING, United Kingdom)

    Objective: To review the impact of Covid 19 on symptoms and signs of Parkinsons as well as general being in patients with Parkinson’s Disease at…
  • 2022 International Congress

    Risk of Long-term Care Admissions Among Medicare Patients Treated with Pimavanserin or Other Atypical Antipsychotics for Parkinson’s Disease Psychosis

    S. Kumar, N. Rashid, D. Doshi, K. Rajagopalan (Dover, USA)

    Objective: To examine all-cause long-term care (LTC) admission risk among PDP patients treated with atypical antipsychotic (AAP). Background: Risk of LTC-admissions associated with off-label AAPs…
  • 2022 International Congress

    Neuropsychological evaluation of cerebellar cognitive function in a series of patients with genetically confirmed CANVAS.

    I. Albajar, J. Equiza, A. Lopez-de-Munain, M. Barandiaran, A. Pujol Onofre, J. Ruiz, M. Maneiro, E. Mondragon, A. Vargas, V. Velez, M. Ruiz Sales, E. Verdura Peralta, P. Iruzubieta (San Sebastian, Spain)

    Objective: We aim to present the cerebellar cognitive affective evaluation and phenotypic description of a series of genetically confirmed CANVAS. Background: Cerebellar ataxia, neuropathy and…
  • 2022 International Congress

    A Week in the Life with Parkinson’s Disease: A Holistic Overview from Four Digital Technologies

    E. Hartman, K. Dinesh, M. Pawlik, S. Jensen-Roberts, E. Waddell, T. Myers, J. Soto, E. Nnadika, P. Yang, G. Sharma, M. Islam, A. Abdelkader, W. Rahman, V. Antony, E. Hoque, G. Zhang, Y. Liu, D. Katabi, R. Wilson, K. Lizarraga, C. Tarolli, R. Schneider, E. Dorsey, J. Adams (Rochester, USA)

    Objective: To showcase a day in the life of a person with Parkinson’s disease (PD) using four multimodal digital technologies. Background: Assessments of PD are…
  • 2022 International Congress

    Has the COVID-19 pandemic had an impact on Functional Movement Disorders phenotype?: experience from a specialized Unit in Spain.

    A. López-Jiménez, JD. Guerra-Hiraldo, M. Kurtis, I. Pareés (Madrid, Spain)

    Objective: To assess the prevalence of paroxysmal functional movement disorders (PFMD) seen in a specialized Unit before and after the COVID-19 pandemic. Background: COVID-19 pandemic…
  • 2022 International Congress

    Eye closure during tasks in blepharospasm (BSP)

    P. Kassavetis, E. Shamim, K. Gottfried, M. Hallett (Salt Lake City, USA)

    Objective: To quantify modulation of eye closure rates during activities of daily living in individuals with BSP and asymptomatic individuals with and without family history…
  • « Previous Page
  • 1
  • …
  • 581
  • 582
  • 583
  • 584
  • 585
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley